Additionally, t(6;9)/DEK::NUP214, a high-risk lesion detected in ~1% of patients with AML, is also amenable to serial RT-qPCR to detect persistent or relapsing disease [20]. This evidence concerns the gene NUP214 and acute myeloid leukemia.